Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

被引：0
|
作者：
Prooksa Ananchuensook
Supachaya Sriphoosanaphan
Sirinporn Suksawatamnauy
Nipaporn Siripon
Nutcha Pinjaroen
Nopavut Geratikornsupuk
Stephen J. Kerr
Kessarin Thanapirom
Piyawat Komolmit
机构：
[1] Chulalongkorn University,Division of Gastroenterology, Department of Medicine, Faculty of Medicine
[2] King Chulalongkorn Memorial Hospital,Center of Excellence in Liver Diseases
[3] Thai Red Cross Society,Liver Fibrosis and Cirrhosis Research Unit
[4] Chulalongkorn University,Department of Radiology, Faculty of Medicine
[5] Chulalongkorn University,Department of Medicine
[6] Queen Savang Vadhana Memorial Hospital,Center of Excellence in Biostatistics, Faculty of Medicine
[7] Chulalongkorn University,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
Easy albumin-bilirubin score; Intermediate-stage hepatocellular carcinoma; Trans-arterial chemoembolization; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
    Roth, Gael S.
    Benhamou, Maxime
    Teyssier, Yann
    Seigneurin, Arnaud
    Abousalihac, Melodie
    Sengel, Christian
    Seror, Olivier
    Ghelfi, Julien
    Ganne-Carrie, Nathalie
    Blaise, Lorraine
    Sutter, Olivier
    Decaens, Thomas
    Nault, Jean-Charles
    CANCERS, 2021, 13 (04) : 1 - 13
  • [22] Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization
    Xu, Weiyu
    Xiong, Jianping
    Lin, Jianzhen
    Long, Junyu
    Bai, Yi
    Zheng, Yongchang
    Xue, Hongyu
    Sang, Xinting
    Zhao, Haitao
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (04) : 1122 - 1134
  • [23] Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma
    Endo, Kei
    Kuroda, Hidekatsu
    Oikawa, Takayoshi
    Okada, Yohei
    Fujiwara, Yudai
    Abe, Tamami
    Sato, Hiroki
    Sawara, Kei
    Takikawa, Yasuhiro
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1575 - 1583
  • [24] Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization
    Prajapati, Hasmukh J.
    Kim, Hyun S.
    PLOS ONE, 2017, 12 (02):
  • [25] Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Ho, Shu-Yein
    Liu, Po-Hong
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Liao, Jia-, I
    Su, Chien-Wei
    Hou, Ming-Chih
    Huo, Teh-Ia
    CANCERS, 2023, 15 (07)
  • [26] Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ando, Yuwa
    Kawaoka, Tomokazu
    Amioka, Kei
    Naruto, Kensuke
    Ogawa, Yutaro
    Yoshikawa, Yuki
    Kikukawa, Chihiro
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Tsuge, Masataka
    Hiramatsu, Akira
    Fukuhara, Takayuki
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Nonaka, Michihiro
    Hyogo, Hideyuki
    Aisaka, Yasuyuki
    Masaki, Keiichi
    Honda, Yoji
    Moriya, Takashi
    Naeshiro, Noriaki
    Takahashi, Shoichi
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    ONCOLOGY, 2021, 99 (08) : 507 - 517
  • [27] TUMOR NUMBER IMPROVES THE PROGNOSTIC VALUE OF HEPATOMA ARTERIAL-EMBOLIZATION SCORE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH CHEMOEMBOLIZATION
    Park, Y.
    Kim, S. U.
    Kim, B. K.
    Park, J. Y.
    Kim, D. Y.
    Ahn, S. H.
    Park, Y. E.
    Park, J. H.
    Lee, Y. I.
    Yun, H. R.
    Han, K. -H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S453 - S454
  • [28] Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
    Yehyun Park
    Beom Kyung Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Jong Eun Yeon
    Kwan Soo Byun
    Hye Soo Kim
    Ji Hoon Kim
    Seung Up Kim
    BMC Cancer, 19
  • [29] Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis
    Chen Shuanggang
    Shi Mengting
    Shen Lujun
    Qi Han
    Wan Weiqi
    Cao Fei
    Xie Lin
    Wu Ying
    Chen Guanjian
    Mo Jinqing
    Zhu Guolian
    Ye Dongdong
    Zhang Yinqi
    Feng Ziqing
    Xu Li
    Fan Weijun
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2020, 37 (01) : 384 - 391
  • [30] Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
    Izumoto, Hirofumi
    Hiraoka, Atsushi
    Ishimaru, Yoshihiro
    Murakami, Tadashi
    Kitahata, Shogo
    Ueki, Hidetaro
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Miyamoto, Yuji
    Yamago, Hiroka
    Iwasaki, Ryuichiro
    Tomida, Hideomi
    Mori, Kenichiro
    Kishida, Masato
    Tsubouchi, Eiji
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Abe, Masanori
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 120 - 126
12345